Explore ideas.
Inform your next move.

RESOURCE

Pre- and Post-launch RWD Analysis Ensures Successful Cancer Therapy Commercialization

RESOURCE

Harmonized Lab Data Analysis Helps Pharma Company Fight Rare Disease

See how timelier data-driven insights enabled faster identification and targeting of potential rare disease patients and treating HCPs.

RESOURCE

New industry evidence demands RWD disruption in pharma

Reuters Events, in partnership with Prognos Health, surveyed 215 brand, marketing, commercial strategy, medical affairs, and data science professionals in the pharmaceutical industry to understand current challenges and opportunities with real-world data (RWD) for therapy commercialization.

RESOURCE

How small and midsize pharma gain economies of scale with an end-to-end RWD Solution

RESOURCE

Real World Data in Life Sciences

RESOURCE

Prognos Factor Explained

Analyzing de-identified patient data is essential to optimize commercial brand strategy. But current methods of obtaining this data can be challenging. See how you can accelerate your path to clinical truth with interoperable patient data and analytics software.

RESOURCE

Accelerate Value Across The Pharma Commercial Lifecycle

RESOURCE

Power Your HCP Outreach with RWD and an Omnichannel Pharma Portal

RESOURCE

The Formula for Generating Faster Patient Level Real World Data Insights

RESOURCE

[Ebook] Accelerate Pharma Value with Marketplace Buying

RESOURCE

[Webinar] Accelerate Time-to-Value via Health Data Integration

RESOURCE

Power Veeva Suggestions with Prognos Alerts

RESOURCE

Better Support for Pharma Commercial Teams with Real World Data Analytics & Omnichannel Solutions

RESOURCE

Patient Cohort Software Demo: Cohort Designer on Prognos Factor®

RESOURCE

Pharma Launch Planning – Build Your Brand Cohort and They Will Come

RESOURCE

[VIDEO] Patient Journey

RESOURCE

Patient Journey Platform Enables Faster Insights